• About us
• Contact

Advertisement

Person › Details

Thomas Strüngmann (STRÜNGMANN Group (family Strüngmann))

Strüngmann, Thomas (Hexal founder + Biotech investor)

 

	Organisation	STRÜNGMANN Group (family Strüngmann)
	Former/major organisation	Hexal AG
	Group	Novartis (Group)

Record changed: 2024-07-03

Advertisement

More documents for Thomas Strüngmann

• [1] Haya Therapeutics SA. (7/1/24). "Press Release: Haya Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award". Lausanne & San Diego, CA....
• [2] AC Immune S.A.. (7/27/21). "Press Release: AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH". Lausanne....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.